Physician profile
Melanie Amster
NPI 1770570798
$8,919.46
in general payments reported to CMS, 2019-2025
50 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $493 · 2021: $700 · 2022: $874 · 2023: $2,000 · 2024: $2,048 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,888.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $885.00 | 2021-2024 | Interstim |
| Astellas Pharma US INC | $870.83 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $750.60 | 2019-2024 | Provenge |
| Abbvie INC. | $558.78 | 2019-2025 | Botox |
| Janssen Biotech, INC. | $542.17 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $459.37 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $432.03 | 2019-2025 | |
| Cook Medical LLC | $378.79 | 2023-2025 | Litho 150, Fiber Dust, Cook |
| Bayer Healthcare Pharmaceuticals INC. | $373.28 | 2019-2025 | |
| Boston Scientific Corporation | $339.94 | 2022-2025 | Lithovue, Bulkamid, Spaceoar System |
| Tolmar, INC. | $335.36 | 2023-2025 | Jatenzo, Eligard |
| Teleflex LLC | $277.67 | 2022-2025 | Urolift, Barrigel |
| Medtronic USA, INC. | $223.15 | 2019-2020 | |
| Immunitybio, INC. | $213.74 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $166.41 | 2021-2025 | Lynparza |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $162.37 | 2022-2024 | Pylarify |
| Urovant Sciences INC | $143.98 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $141.45 | 2022-2025 | Lynparza, Keytruda |
| Coloplast Corp | $137.67 | 2019-2025 | |
| Axonics, INC. | $136.69 | 2022-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $130.64 | 2019 | |
| Telix Pharmaceuticals | $125.76 | 2023-2025 | Illuccix |
| Urogen Pharma, INC. | $116.20 | 2021-2025 | |
| Bioprotect Medical, INC. | $96.76 | 2024 | Bioprotect Balloon Implant System |
| Ethicon US, LLC | $92.67 | 2023 | Surgicel Nu-Knit, Vistaseal, Evarrest |
| Intuitive Surgical, INC. | $84.74 | 2020 | |
| 180 Medical, INC. | $68.65 | 2019-2021 | |
| Valencia Technologies Corporation | $59.58 | 2025 | Ecoin Device Kit |
| Vertex Pharmaceuticals Incorporated | $57.17 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $53.11 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $52.71 | 2024-2025 | Itind System |
| Novartis Pharmaceuticals Corporation | $41.13 | 2025 | |
| Baxter Healthcare | $36.30 | 2023 | Tisseel |
| Accord Healthcare, INC. | $36.18 | 2022-2023 | |
| Allergan, INC. | $31.71 | 2020-2022 | |
| Verity Pharmaceuticals INC. | $31.16 | 2023-2024 | Trelstar |
| Procept Biorobotics Corporation | $30.87 | 2024-2025 | Aquabeam System |
| Civco Medical Instruments | $29.25 | 2025 | |
| Acerus Pharmaceuticals Corporation | $24.17 | 2021 | |
| Avyxa Pharma, LLC | $23.86 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $22.80 | 2019 | |
| Blue Earth Diagnostics | $20.57 | 2021 | |
| Clarus Therapeutics INC. | $19.50 | 2021 | |
| Amgen INC. | $16.92 | 2019 | |
| Mimedx Group, INC. | $16.41 | 2025 | |
| Clovis Oncology, INC. | $15.32 | 2021 | |
| Mission Pharmacal Company | $14.91 | 2022 | |
| Myovant Sciences INC. | $14.66 | 2021 | |
| Avation Medical, INC. | $14.41 | 2025 | Vivally System |
| Photocure INC | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Amster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.